Media report · AI-ASSISTED BRIEF
Isomorphic Labs Raises $5B Series C to Push AI-Designed Drugs Toward Clinical Trials
Report publication · YYSI publication
According to TechCrunch, Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and existing backers including Alphabet's GV and CapitalG participating. The company says its simulation-model drug-design engine has produced positive preclinical results in oncology and immunology, and it will use the funds to advance candidates toward clinical trials and expand into more medicine types.
Source & context
techcrunch.com · Read the original source ↗
This AI-assisted brief attributes information to the linked media report. It is not an official announcement or independent YYSI reporting. Consult the original report and its evidence.